Product Images Levetiracetam

Levetiracetam is a medication that comes in the form of a film-coated tablet that contains 500mg of the active ingredient. This medication is usually dispensed in a container that is child-resistant and light-resistant. The recommended storage temperature is between 20°C to 25°C. The medication guide for this product is available online. The manufacturer of this medication is Hetero Labs Limited, and it is produced in India for Northstar Rx LLC. The dosage information can be found in the package insert.*

This is a description of Northstair Levetiracetam tablets, USP containing 500 mg of the active ingredient. The suggested use is to dispense with a medication guide that is provided separately. The tablets come in a package of 500 with instructions to store them in a tight, light-resistant container with a child-resistant closure. The recommended storage temperatures are between 20°C to 25°C. For complete dosage recommendations, pharmacists can refer to the package insert or the North Starr website. The tablets are manufactured in India and distributed by Northstar Rx LLC.*

Levetiracetam is a type of medication available in the form of tablets. The tablets are film-coated and each tablet contains 500 mg of levetiracetam USP. The medication must be dispensed in a tight, light-resistant container with child-resistant closure. The usual dosage is available in the package insert. The medication guide is available at www.northstarrxlc.com/products or by calling. This medication is manufactured by Annora Pharma Put. Ltd. and distributed by Northstar Rx LLC, Memphis, TH. It is a product of India.*

This appears to be a chart showing the percentage of patients in different treatment groups, including a placebo group, with varying doses of a medication called Levetiracetam. The chart also includes a scale from 0% to 45%.*

This text presents a table with the number of patients (N) in each group (Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day) and the percentage of patients in each group. No further information is available.*

This text provides a tabular representation of the percentage of patients in two groups: Placebo (N=104) and Levetiracetam 3000 mg/day (N=180). However, without additional context, the purpose of the analysis and the outcome measured cannot be determined.*

This text provides the percentage of patients who were treated with either placebo or Levetiracetam (N= number of participants in each group). The placebo group had 97 patients with 44.6% responsiveness while the Levetiracetam group had 101 patients. No specific information is given about the percentage of responsiveness in the Levetiracetam group.*

This text is a representation of the percent of patients who received either Placebo or Levetiracetam treatment, along with the number of patients who received each treatment. Specifically, 19.6% (51 patients) received Placebo, while 43.1% (58 patients) received Levetiracetam.*

This is a clinical data table showing the percentage of patients in two groups, Placebo (N=84) and Levetiracetam (N=79), with their respective response rates to the treatment. The table displays the response rate percentages vertically from 0% to 100%, with increments of 10% and identifies the response rate percentages for each group.*

Levetiracetam is a medication provided in a bottle of 120 film-coated tablets, each containing 250 mg of levetiracetam USP. The pharmacist must dispense it in a light-resistant container with a child-resistant closure. The usual dosage should be checked on the package insert. It should be stored at 20-25°C. Northstar LLC manufactures it, and Hetero Labs Ltd. in Hyderabad, India. Medication guides are available on their company website or by phone. Batch coding number 2059433 with the manufacturing licensing number of 22/RRIAPI2001/FIR issued in 0312022.*

Each tablet of this medication contains 750mg of levetiracetam USP. The recommended dosage can be found in the package insert. The tablets should be stored at controlled room temperature and dispensed in a light-resistant container with a child-resistant closure. This medication is manufactured in India and distributed by Northstar Rx LLC of Memphis, TN. A medication guide may be provided separately. Expires in March of 2022.*

Each film-coated tablet of Levetiracetam USP 250 mg is contained in a child-resistant package with a tight and light-resistant seal. Dosage recommendations are available in the package insert. This product is manufactured by Hetero Labs Limited in India and distributed by Northstar Rx LLC in Memphis, TN. A medication guide is included separately.*

Levetiracetam Tablets, USP 750mg in a bottle of 500 tablets. This medicine is dispensed with a medication guide that is provided separately. Each film-coated tablet contains 750mg of Levetiracetam USP. It should be dispensed in a child-resistant light-resistant container by the pharmacist. Dosage should be as prescribed in the package insert, and the medication should be stored at 20°C to 25°C. Medication guides are available at the manufacturer's website or through their hotline. The product is manufactured in India by Hetero Labs Limited and distributed by Northstar Rx LLC, Memphis, TN 38141. The manufacturing license number is 22/RRIAP/2001/FIR.*